Literature DB >> 2470230

In vivo and in vitro staining of acidophilic neurons as indicative of cell death following kainic acid-induced lesions in rat brain.

G J Lees1.   

Abstract

An in vivo method for positively staining dead neurons was developed and compared with an in vitro staining method using acid fuchsin. Neurons previously killed by intracerebral injections of kainic acid were selectively stained by trypan blue within 15 min of its injection in vivo into the central nervous system of rats. Such staining persisted for at least 4 days in vivo, and there was no evidence that trypan blue itself was toxic to the remaining cells. Intense staining of neurons with acid fuchsin in vitro was first observed in brain sections of rats killed about 6h after kainic acid injection. This time was approximately 2-3 h before trypan blue, in vivo, was able to stain neurons. Thus, the loss of transport mechanisms (at least for trypan blue) apparently occurs subsequent to the development of basic products stainable with acidic dyes. At the earliest times, acid fuchsin stained neurons which had not yet lost Nissl substance, whereas the majority of trypan blue-stained neurons were not stained with Nissl dyes. After 24 h the majority of neurons stained with either acid fuchsin or trypan blue were Nissl-stain negative. The combination of staining with trypan blue in vivo with subsequent counterstaining of brain sections with acid fuchsin in vitro may have a potential use in the determination of the time of neuronal death in vivo.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2470230     DOI: 10.1007/bf00687254

Source DB:  PubMed          Journal:  Acta Neuropathol        ISSN: 0001-6322            Impact factor:   17.088


  16 in total

Review 1.  Limbic seizure and brain damage produced by kainic acid: mechanisms and relevance to human temporal lobe epilepsy.

Authors:  Y Ben-Ari
Journal:  Neuroscience       Date:  1985-02       Impact factor: 3.590

2.  Use of excitatory amino acids to make axon-sparing lesions of hypothalamus.

Authors:  J V Nadler; D A Evenson
Journal:  Methods Enzymol       Date:  1983       Impact factor: 1.600

Review 3.  Neurotoxic action of kainic acid.

Authors:  J T Coyle
Journal:  J Neurochem       Date:  1983-07       Impact factor: 5.372

4.  Degeneration of hippocampal CA3 pyramidal cells induced by intraventricular kainic acid.

Authors:  J V Nadler; B W Perry; C Gentry; C W Cotman
Journal:  J Comp Neurol       Date:  1980-07-15       Impact factor: 3.215

5.  Widespread patterns of neuronal damage following systemic or intracerebral injections of kainic acid: a histological study.

Authors:  J E Schwob; T Fuller; J L Price; J W Olney
Journal:  Neuroscience       Date:  1980       Impact factor: 3.590

6.  Morphologic effect of dimethyl sulfoxide on the blood-brain barrier.

Authors:  R D Broadwell; M Salcman; R S Kaplan
Journal:  Science       Date:  1982-07-09       Impact factor: 47.728

7.  Kainic acid seizures and the reversibility of calcium loading in vulnerable neurons in the hippocampus.

Authors:  M C Evans; T Griffiths; B S Meldrum
Journal:  Neuropathol Appl Neurobiol       Date:  1984 Jul-Aug       Impact factor: 8.090

8.  Local and distant neuronal degeneration following intrastriatal injection of kainic acid.

Authors:  R Zaczek; S Simonton; J T Coyle
Journal:  J Neuropathol Exp Neurol       Date:  1980-05       Impact factor: 3.685

9.  The temporal evolution of hypoglycemic brain damage. I. Light- and electron-microscopic findings in the rat cerebral cortex.

Authors:  R N Auer; H Kalimo; Y Olsson; B K Siesjö
Journal:  Acta Neuropathol       Date:  1985       Impact factor: 17.088

10.  Ischemic CA-1 pyramidal cell loss is prevented by preischemic colchicine destruction of dentate gyrus granule cells.

Authors:  F F Johansen; M B Jørgensen; N H Diemer
Journal:  Brain Res       Date:  1986-07-09       Impact factor: 3.252

View more
  1 in total

1.  Zinc accumulation after target loss: an early event in retrograde degeneration of thalamic neurons.

Authors:  Peter W Land; Elias Aizenman
Journal:  Eur J Neurosci       Date:  2005-02       Impact factor: 3.386

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.